chr2-203936855-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_012092.4(ICOS):c.41G>A(p.Arg14His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000432 in 1,458,154 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R14C) has been classified as Benign.
Frequency
Consequence
NM_012092.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ICOS | NM_012092.4 | c.41G>A | p.Arg14His | missense_variant | 1/5 | ENST00000316386.11 | |
LOC101927840 | XR_427213.4 | n.314+462C>T | intron_variant, non_coding_transcript_variant | ||||
ICOS | XR_007073112.1 | n.93G>A | non_coding_transcript_exon_variant | 1/6 | |||
ICOS | XM_047444022.1 | upstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ICOS | ENST00000316386.11 | c.41G>A | p.Arg14His | missense_variant | 1/5 | 1 | NM_012092.4 | P2 | |
ICOS | ENST00000435193.1 | c.41G>A | p.Arg14His | missense_variant | 1/4 | 1 | A2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 250878Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135672
GnomAD4 exome AF: 0.0000432 AC: 63AN: 1458154Hom.: 0 Cov.: 29 AF XY: 0.0000455 AC XY: 33AN XY: 725628
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Immunodeficiency, common variable, 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 18, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The histidine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 1382633). This variant has not been reported in the literature in individuals affected with ICOS-related conditions. This variant is present in population databases (rs776057192, gnomAD 0.01%). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 14 of the ICOS protein (p.Arg14His). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at